Atria Wealth Solutions Inc. reduced its stake in shares of DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 4.9% during the 4th quarter, Holdings Channel.com reports. The firm owned 9,515 shares of the company’s stock after selling 485 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in DocuSign were worth $566,000 as of its most recent filing with the SEC.
A number of other institutional investors have also modified their holdings of DOCU. Capital Analysts LLC grew its holdings in DocuSign by 781.7% during the fourth quarter. Capital Analysts LLC now owns 529 shares of the company’s stock worth $31,000 after acquiring an additional 469 shares during the period. BluePath Capital Management LLC purchased a new position in shares of DocuSign during the 3rd quarter valued at approximately $32,000. McGlone Suttner Wealth Management Inc. acquired a new position in shares of DocuSign in the 4th quarter valued at $32,000. Performa Ltd US LLC boosted its holdings in DocuSign by 50.0% during the third quarter. Performa Ltd US LLC now owns 825 shares of the company’s stock worth $35,000 after buying an additional 275 shares in the last quarter. Finally, Whittier Trust Co. grew its position in DocuSign by 28.8% during the fourth quarter. Whittier Trust Co. now owns 935 shares of the company’s stock valued at $56,000 after buying an additional 209 shares during the period. Hedge funds and other institutional investors own 77.64% of the company’s stock.
Insider Buying and Selling
In other DocuSign news, CEO Allan C. Thygesen sold 7,765 shares of the company’s stock in a transaction on Friday, March 1st. The stock was sold at an average price of $53.31, for a total value of $413,952.15. Following the completion of the sale, the chief executive officer now directly owns 104,002 shares in the company, valued at approximately $5,544,346.62. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, CEO Allan C. Thygesen sold 7,765 shares of the business’s stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $53.31, for a total transaction of $413,952.15. Following the transaction, the chief executive officer now owns 104,002 shares of the company’s stock, valued at approximately $5,544,346.62. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Peter Solvik sold 15,000 shares of the company’s stock in a transaction dated Tuesday, April 9th. The shares were sold at an average price of $60.00, for a total transaction of $900,000.00. Following the completion of the sale, the director now directly owns 783 shares of the company’s stock, valued at approximately $46,980. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 55,277 shares of company stock worth $3,159,756. 17.80% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
Check Out Our Latest Research Report on DOCU
DocuSign Trading Up 1.8 %
NASDAQ:DOCU opened at $59.80 on Monday. The company has a market cap of $12.28 billion, a P/E ratio of 166.11, a P/E/G ratio of 5.17 and a beta of 0.88. DocuSign, Inc. has a twelve month low of $38.11 and a twelve month high of $64.76. The company’s 50-day moving average price is $57.24 and its 200-day moving average price is $53.38.
DocuSign (NASDAQ:DOCU – Get Free Report) last released its quarterly earnings data on Thursday, March 7th. The company reported $0.15 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.06. The company had revenue of $712.39 million during the quarter, compared to the consensus estimate of $698.05 million. DocuSign had a net margin of 2.68% and a return on equity of 13.91%. On average, analysts expect that DocuSign, Inc. will post 0.87 earnings per share for the current year.
DocuSign Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Stories
- Five stocks we like better than DocuSign
- What Makes a Stock a Good Dividend Stock?
- MarketBeat Week in Review – 4/29 – 5/3
- What Is WallStreetBets and What Stocks Are They Targeting?
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- What is a Dividend King?
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.